APPROVAL AND DISTRIBUTION PERMISSION FOR PFIZER/BIONTECH VACCINE ISSUED IN EUROPEAN UNION


23/12/2020




Selin ATAY-TDO- The European Union (EU) approved the use and authorized distribution today for the vaccine developed by the European Medicines Agency (EMA) against Covid-19.

Following the EMA's decision, EU Commission President Ursula von der Leyen announced that the distribution of vaccines produced at Pfizer's Belgian facilities to European Union members will begin within days with the permission of the EU Commission.

Von der Leyen said vaccinations are expected to begin in all European Union countries on 27, 28 and 29 December. Von der Leyen said EMA will also make a decision on the approval of the vaccine developed by the American pharmaceutical company Moderna on January 6. The EU Commission President also said that as the European Union, they will help low-income countries with the supply of vaccines.

After a meeting of medical experts, the EMA announced that it had taken a recommendation to apply the vaccine to people over the age of 16. In addition, pharmaceutical companies are required to re-submit follow-up data on the vaccine in 2021.

The European Union has secured up to 300 million doses of the vaccine from BioNTech and Pfizer for the Union countries. BioNTech and Pfizer have announced plans to produce 50 million doses this year and 1.3 billion doses in 2021.


porno izlebrazzers